The number nobody publishes
The short answer, as of September 2026: launched on a white-label platform, a single-state telehealth business costs about $20,000 to $45,000 before revenue, ten states run $60,000 to $120,000, and a sequenced 50-state build runs $200,000 to $450,000 or more; assembling the stack yourself adds $60,000 to $250,000 and four to nine months on top. The rest of this post is the line items behind those ranges.
Telehealth launch costs are quoted the way platform pricing is quoted: vaguely, and after a sales call. The honest answer is a set of ranges driven by four choices: how many states you open, how much legal structure you buy up front, how hard you push acquisition in the first quarter, and, the one that moves the total more than any other, whether you assemble the stack yourself or launch on a platform that ships it as one system.
That last choice is the reason two equally serious founders report launch costs an order of magnitude apart. Every launch budget is really two piles. Pile one buys legality and trust: professional entities, clinical coverage, insurance, compliant structure. Pile two buys infrastructure: storefront, intake, billing, pharmacy connections, patient portal, and the engineering to hold them together. Pile one is unavoidable. Pile two is optional, because platforms like Turbopills exist to absorb it. Most of this post is about pricing both piles honestly.
If you have not yet sequenced the launch itself, the operational order of operations is in the DTC telehealth launch checklist.
Updated September 22, 2026: added a by-vertical cost table, a LegitScript line ($975 plus $2,150 a year), the platform prices nine vendors now publish ($200 to $5,999 a month), and two third-party budgets (MyOrbitHealth, Karpa Health) to check ours against.
Pile one: the costs every launch pays
| Line item | Typical range | When it hits |
|---|---|---|
| Professional corporation (PC) formation and registration | ~$1,000 per state, 1-2 months each | Before anything clinical |
| MSO formation and MSO-PC agreements (legal) | $3,000-15,000 one time | Weeks 1-4 |
| Medical director / collaborating physician | $500-1,000/month for a collaborating physician, from ~$799/month for a director service, $6,000+/month multi-state | Monthly, from signing |
| Malpractice and business insurance | Low four figures per year to start | Annual, before first patient |
| Platform fees | $200-2,000/month where published, some plus $25 per consult and $9,800-15,000 setup; otherwise quoted | Monthly or per use |
| LegitScript certification | $975 application plus $2,150 per year, per website; $2,500 to expedite | Before Google, Meta, Microsoft, or TikTok ads |
| Pharmacy onboarding | $0-2,500, mostly calendar time | Weeks 2-6 |
| Payment processing reserve | 5-10% of revenue held rolling by the processor | From first sale |
| Initial ad budget | $10,000-30,000 for the first 90 days, single state | From launch week |
| Ops tooling and misc (domain, email, support desk) | $200-500 per month | Monthly |
Four notes on the sneaky ones. Platform fees moved the most since August: Remedora, Karpa Health, MDLaunchr and EmbedCare publish flat fees from $200 to $1,997 a month, Cuvo and Telegra publish $997 to $5,999 plus setup; the full table is in the platform pricing post. LegitScript is a calendar cost as much as a fee: r/telehealth founders reported four to eleven weeks doing it themselves (September 13 and 21, 2026), and no major ad platform runs a prescription campaign without it, so file in week one or pick a platform that bundles the expedite. The MSO-PC structure is what lets a non-physician founder run the business legally in corporate practice of medicine states; the mechanics and why the legal fee is worth paying are in the MSO-friendly PC model explained. The payment processing reserve is your own revenue held back rather than a fee, telehealth is a scrutinized category and processors commonly hold a rolling reserve, so model the cash gap or it becomes a payroll problem; the underwriting side is covered in passing payment processor review. And the ad budget is the line founders most reliably underfund: a launch that cannot afford 90 days of real traffic cannot learn anything.
What each vertical adds to pile one
Pile one is the floor. Each program type adds its own lines, and the deltas below are our estimates for a single-state launch, not quotes. The pharmacy column is the one that changed most this year.
| Vertical | Lab partner setup | Controlled substances and DEA | LegitScript | First-quarter ad budget, single state | Pharmacy type |
|---|---|---|---|---|---|
| GLP-1, branded only | Optional at launch; $0-1,500 to wire a Quest or Labcorp account | None | Standard: $975 plus $2,150/yr | $15,000-30,000; the most expensive clicks in the category | Manufacturer direct (LillyDirect, NovoCare) or retail; plan without compounded copies now that the Fifth Circuit affirmed FDA on Aug 27, 2026 and the 503B order is pending |
| TRT with labs | Required; $500-2,500 setup plus $50-150 per panel, two morning draws before a script | Testosterone is Schedule III: DEA registration $888 per three years per prescriber; telemedicine flexibilities expire Dec 31, 2026 | Standard | $10,000-25,000 | Commercial pharmacy for cypionate, 503A for compounded formats, controlled-substance shipping rules either way |
| Hair loss | Optional; a hormone panel where indicated | None | Standard | $5,000-15,000 | Commercial generic finasteride and minoxidil, or 503A topicals |
| Menopause and HRT | Often; $500-2,500 setup, panels optional under current guidelines | None unless you add testosterone (Schedule III) | Standard | $10,000-20,000 | Commercial branded and generic estradiol and progesterone; 503A for compounded |
| Peptides | Usually; baseline panels at $100-200 per patient | None | Hardest: depends on which peptides you sell (sermorelin, NAD+ and PT-141 are legal today; BPC-157 and TB-500 are not prescribable) | $5,000-15,000, with most creative rejected on Meta, so plan on organic | 503A only, patient-specific |
The TRT row carries the most calendar risk: the DEA's Special Registration final rule went to OIRA on August 25, 2026, and if the flexibilities lapse on December 31 without it, an in-person exam requirement returns for Schedule III scripts. The contingency plan is in the DEA cliff 120-day plan.
Pile two: the self-assembly costs a platform deletes
Now the pile that produces the half-million-dollar launch stories. If you build the stack yourself, or stitch it from single-purpose vendors, the budget grows a second table:
| Self-assembly item | Typical range | What it buys |
|---|---|---|
| Storefront and site build | $10,000-50,000 agency, or months of your own time | Brandable, conversion-ready pages |
| Intake and questionnaire tooling | Setup plus $100-500/month | Eligibility screening, structured charts |
| EHR seats and configuration | $300-1,000+/month plus setup | Charting, e-prescribing rails |
| CRM, support desk, and patient messaging stitching | $200-800/month plus integration time | One view of the patient |
| Subscription billing engineering | $20,000-60,000 contractor work | Recurring charges, retries, refunds |
| Integration glue (pharmacy APIs, webhooks, data sync) | $30,000-100,000 | The stack behaving like one system |
| Calendar cost | 4-9 months before first patient | Burn with zero learning |
This is where the variance lives. Add the middle column up and self-assembly puts $60,000-250,000 of build cost in front of your first patient, and the last row is the expensive one hiding in plain sight: every month spent integrating is a month of team burn, tool subscriptions, and zero market feedback.
An all-in-one platform collapses this entire table into the platform fee from pile one. That is the argument for the category, and it is our argument too: Turbopills ships the storefront, conditional intake, state-aware provider routing, subscription billing, pharmacy fulfillment, and the branded patient portal as one system, so a launch that would otherwise be a six-month integration project becomes a configuration project measured in weeks. We build one of these platforms, so verify that claim in a demo rather than taking it from our blog, but price the alternative honestly first. The head-to-head landscape is in the honest platform comparison, and the deeper make-or-buy math is in the build vs buy analysis.
| Path | Cash before first patient | Calendar |
|---|---|---|
| Single state, on a platform | ~$20,000-45,000 | 60-90 days |
| Single state, self-assembled | ~$80,000-200,000 | 5-9 months |
| 10 states, on a platform | ~$60,000-120,000 | ~90 days |
| 10 states, self-assembled | ~$180,000-350,000+ | 6-12 months |
Two vendors publish their own version of this math. MyOrbitHealth puts a self-built stack at $250,000 to $900,000 or more against $10,000 to $75,000 on a white-label platform; Karpa Health budgets $25,000 to $65,000 for a five-state launch on its platform. Our platform rows bracket Karpa's number and our self-assembled rows sit at the low end of MyOrbitHealth's range, about where a vendor with a build-vs-buy story would draw the line. Discount all three of us the same way: each sells the cheaper column.
Scenario one: bootstrap, single state
The lean version, launched on a platform: one state, one collaborating physician, per-consult or low-fixed platform pricing so fixed costs stay near zero, and a 90-day paid traffic test.
| Line item | Budget |
|---|---|
| PC formation, one state | $1,000-1,500 |
| MSO setup and agreements, lean counsel | $3,000-7,500 |
| Medical director, 3 months | $2,400-3,600 |
| Insurance, year one | $2,000-5,000 |
| Platform, 3 months at low volume | $0-4,500 |
| Pharmacy onboarding | $0-1,000 |
| Ads, first 90 days | $10,000-20,000 |
| Tooling and misc | $600-1,500 |
| Total to first learnings | ~$20,000-45,000 |
Calendar: 60-90 days from incorporation to first patient, with the PC and pharmacy timelines running in parallel. This scenario exists to answer one question, can you acquire patients profitably in one market, before you spend state-expansion money. Notice what makes the number possible at all: nothing in this table is a build. Self-assembling the stack roughly triples this budget before a single ad runs.
Scenario two: the 10-state launch
Ten states is the common "serious from day one" configuration: enough population coverage to make ads efficient, small enough to manage licensure by hand.
| Line item | Budget |
|---|---|
| PC registrations, 10 states | $10,000-12,000 |
| MSO setup and agreements | $7,500-15,000 |
| Clinical coverage, 3 months | $4,500-9,000 |
| Insurance, year one | $4,000-8,000 |
| Platform, first quarter | $3,000-9,000 |
| Pharmacy onboarding | $0-2,500 |
| Ads, first 90 days | $30,000-60,000 |
| Tooling and misc | $1,500-3,000 |
| Total | ~$60,000-120,000 |
The constraint here is rarely money, it is the 1-2 months per state of entity and licensure calendar. Start every state's paperwork in week one and let them land on a rolling basis rather than gating launch on the slowest state. On a platform, the infrastructure is ready before the paperwork is, which turns state entities into the critical path and keeps the burn clock short.
Scenario three: 50 states, sequenced
Nobody should write one check for 50 states on day one. The honest 50-state budget is a sequenced program over four to six months, opened in tranches ordered by population, licensure speed, and compact leverage, the sequencing logic is in the 50-state rollout plan.
| Line item | Budget |
|---|---|
| PC registrations, 50 states | $45,000-60,000 |
| Legal structure and counsel | $15,000-30,000 |
| Clinical team (director plus collaborating physicians), first quarter | $15,000-30,000 |
| Insurance | $10,000-25,000 |
| Platform, first quarter at volume | $10,000-30,000 |
| Pharmacy, multiple partners | $2,500-5,000 |
| Ads, first quarter | $100,000-250,000 |
| Support and ops staffing, first quarter | $5,000-20,000 |
| Total | ~$200,000-450,000+ |
At this tier the platform decision compounds hardest, in both directions. Per-consult pricing that felt cheap at 100 consults a month reads differently at 3,000, so run every quote against your own volume curve. And the self-assembly premium scales worst of all: at 50-state volume the integration glue, billing engineering, and data sync from pile two become a standing engineering team, not a one-time contractor invoice. This is the tier where "we saved money building it ourselves" stories quietly become infrastructure companies that also see patients.
Where founders overspend and underspend
The pattern across launches we see is consistent. Overspent: legal gold-plating in month one (a $25,000 contract stack for a business with zero patients), branding projects, and above all custom software, rebuilding infrastructure that platforms already run at higher reliability than a launch team can afford. Underspent: the ad budget, the payment reserve cash gap, and insurance review. The cheapest launch is not the one with the smallest total, it is the one where every dollar bought either legality or learning. Entity work and clinical coverage buy legality. Traffic buys learning. A platform fee buys back the entire second pile plus the months it would have burned. Most everything else can wait until revenue argues for it.
FAQ
How much does it cost to start a telehealth business in 2026? Launched on a white-label platform, a bootstrap single-state DTC telehealth launch typically runs $20,000-45,000 before revenue, a 10-state launch runs roughly $60,000-120,000, and a sequenced 50-state buildout runs $200,000-450,000 or more. Self-assembling the stack instead adds roughly $60,000-250,000 of build cost and four to nine months of calendar time on top.
How do platforms like Turbopills reduce telehealth launch costs? They collapse the self-assembly pile, storefront build, intake tooling, billing engineering, pharmacy integrations, patient portal, and the glue code between them, into a single platform fee, and compress the pre-revenue calendar from months to weeks. The costs that remain are the ones that buy legality and growth: entities, clinical coverage, insurance, and ads.
How much does a telehealth medical director cost? Placement services advertise medical directors from about $799 per month; nurse practitioners report collaborating physicians at $500 to $1,000 a month (r/PMHNP, May 15, 2026); LocumTele quoted about $500 a month single-state to $6,000 or more multi-state on September 10, 2026. Budget it as a permanent monthly line, not a setup cost. Sourcing and vetting are covered in the medical director hiring guide.
Are telehealth companies profitable? The public ones are, at scale: Hims & Hers reported $753.2 million of Q2 2026 revenue at a 64% gross margin after its shift to branded drugs, and LifeMD runs near 89% with an in-house pharmacy. A small brand's question is different: at $149 a month a 500-patient program grosses about $74,500 a month, and whether that clears pile one depends mostly on acquisition cost. The math by patient count is in DTC telehealth unit economics: benchmarks from public filings.
What is the most commonly missed launch cost? The payment processing reserve. Processors commonly hold 5-10% of a telehealth merchant's revenue on a rolling basis during the early months, which is a working-capital gap most launch budgets never model.